4.1 Article

Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) Updated statement of the Austrian Society of Pneumology (ASP)

期刊

WIENER KLINISCHE WOCHENSCHRIFT
卷 134, 期 9-10, 页码 399-419

出版社

SPRINGER WIEN
DOI: 10.1007/s00508-022-02018-x

关键词

Mechanical ventilation; Immune modulators; Chronic lung disease; Pediatric lung disease; Long covid

资金

  1. Medical University of Graz

向作者/读者索取更多资源

The Austrian Society of Pneumology (ASP) released a statement on SARS-CoV-2 infection, highlighting the impact of the virus variants, particularly the delta and omicron variants. The statement also addresses the risks and precautions for patients with chronic lung diseases and healthcare professionals who provide care to these patients.
The Austrian Society of Pneumology (ASP) launched a first statement on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in Austria 285 people had died from this disease and vaccinations were not available. Lockdown and social distancing were the only available measures to prevent more infections and the breakdown of the health system. Meanwhile, in Austria over 13,000 patients have died in association with a SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) was among the most common causes of death; however, SARS-CoV-2 has been mutating all the time and currently, most patients have been affected by the delta variant where the vaccination is very effective but the omicron variant is rapidly rising and becoming predominant. Particularly in children and young adults, where the vaccination rate is low, the omicron variant is expected to spread very fast. This poses a particular threat to unvaccinated people who are at elevated risk of severe COVID-19 disease but also to people with an active vaccination. There are few publications that comprehensively addressed the special issues with SARS-CoV-2 infection in patients with chronic lung diseases. These were the reasons for this updated statement. Pulmonologists care for many patients with an elevated risk of death in case of COVID-19 but also for patients that might be at an elevated risk of vaccination reactions or vaccination failure. In addition, lung function tests, bronchoscopy, respiratory physiotherapy and training therapy may put both patients and health professionals at an increased risk of infection. The working circles of the ASP have provided statements concerning these risks and how to avoid risks for the patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据